View the TENOVIR registration information details.
Back to drug list
ItemsDrug Registration information
ID2222
No2222
Brand NameTENOVIR
IngredientsTENOFOVIR DISOPROXIL FUMARATE 300 MG
Dosage FormFILM COATED TABLET
Primary PackagingBOTTLE
Storage
Shelf Life2 YEARS
Pack Size30 TABLETS/BOTTLE
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsINDICATED IN COMBINATION WITH OTHER ANTIRETROVIRAL AGENTS FOR THE TREATMENT OF HIV -1 INFECTIONS IN ADULTS AND PEDIATRIC PATIENTS 2 YEARS OF AGE AND OLDER. FOR THE TREATMENT OF CHORNIC HEPATITIS B IN ADULTS AND PEDIATRIC PATIENTS 12 YEARS OF AGE AND OLDER.
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionPINK COLOUR OBLONG FILM COATED TABLET WITH P-L AT ONE SIDE AND CUT MARK ON OTHER SIDE.
Note
License OwnerPOUNSAB PHARMA CO.,LTD
ManufacturerPHARMIX LABORATORIES (PVT ) LTD
CountryPAKISTAN
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No09 I 4188/16
FDD Registration Date02/11/2023
Expiry Date01/11/2026
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA